vTv Therapeutics (VTVT) Return on Sales (2014 - 2026)

vTv Therapeutics has disclosed Return on Sales across 13 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, up 1348.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 1347.0% YoY), and the FY2024 annual result was 0.22%, changed N/A from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at vTv Therapeutics, up from 16.69% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2026 to a low of 30.68% in Q3 2023.
• The 5-year median for Return on Sales is 4.55% (2022), against an average of 8.58%.
• Across the five-year window, Return on Sales sank 3054 bps in 2023 and soared 3046 bps in 2024, its largest moves.
• vTv Therapeutics' Return on Sales stood at 6.77% in 2022, then plunged by 353 bps to 30.68% in 2023, then surged by 91 bps to 2.61% in 2024, then plunged by 540 bps to 16.69% in 2025, then soared by 100 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 16.69% (Q3 2025), and 14.04% (Q2 2025), per Business Quant data.